Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is: 1) To document the effectiveness and tolerability of paroxetine
for the treatment of subthreshold posttraumatic stress disorder (PTSD) in veterans in the
early post-deployment period; and 2) To determine the potential efficacy of paroxetine in
preventing the progression of anxiety symptoms to PTSD and other anxiety disorders, and
improving overall veteran function.